JPMorgan Chase & Co. Cuts Zimmer Biomet (NYSE:ZBH) Price Target to $105.00
Zimmer Biomet (NYSE:ZBH – Free Report) had its price target cut by JPMorgan Chase & Co. from $128.00 to $105.00 in a research note published on Tuesday,Benzinga reports. They currently have an overweight rating on the medical equipment provider’s stock. A number of other equities research analysts have also issued reports on the stock. Robert […]
Zimmer Biomet (NYSE:ZBH – Free Report) had its price target cut by JPMorgan Chase & Co. from $128.00 to $105.00 in a research note published on Tuesday,Benzinga reports. They currently have an overweight rating on the medical equipment provider’s stock. A number of other equities research analysts have also issued reports on the stock. Robert […]
